Novel Selective Cyp26 Antagonists for Dermatological Diseases
Cyp26 inhibitor compounds treat diseases such as psoriasis, while avoiding retinoid related side affects.
- 1 US provisional patent application and another PCT application: both claiming novel but separate compositions of matter for inhibition of either Cyp26A1 or Cyp26B1
- Patent application submitted
- Provisional patent
- University spin out
- Development partner
- Seeking investment